e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Cystic fibrosis: advances in clinical research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genotype based evaluation of eradication treatment for
p. aeruginosa
infections in CF patients
P. Schelstraete, P. Deschaght, L. Van Simaey, S. Van Daele, F. Haerynck, M. Vaneechoutte, F. De Baets (Ghent, Belgium)
Source:
Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Session:
Cystic fibrosis: advances in clinical research
Session type:
Thematic Poster Session
Number:
1266
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Schelstraete, P. Deschaght, L. Van Simaey, S. Van Daele, F. Haerynck, M. Vaneechoutte, F. De Baets (Ghent, Belgium). Genotype based evaluation of eradication treatment for
p. aeruginosa
infections in CF patients. Eur Respir J 2009; 34: Suppl. 53, 1266
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Correlation between eradication of infecting organism on days 3-5 of antibiotic therapy and clinical cure in patients with acute exacerbations of chronic bronchitis (AECB)
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Clinical cure rates and infection types in the MOxifloxacin Treatment IV (MOTIV) study in hospitalized patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006
IFN-γ response on T-cell based assays for the diagnosis of tuberculosis infection in rheumatic patients undergoing anti-TNF-α treatment
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
Source: Eur Respir J 2015; 45: 1170-1173
Year: 2015
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016
Comparison of compliance of two therapeutic regimens in treatment of latent tuberculosis infection in Belgrade children
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004
Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006
The usage of laferon in treatment of patients with community acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 675s
Year: 2007
Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Clinical, radiological and bacteriological features in geriatric tuberculosis (TB) patients (pts) - initial treatment and outcome
Source: Eur Respir J 2002; 20: Suppl. 38, 363s
Year: 2002
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008
A choice of regimen improves completion for patients with latent TB infection
Source: Breathe 2008; 4: 366
Year: 2008
Efficacy of using special software “Optimization of medication choice for treatment of patient with comorbidity” (SS) for management of patients with community-acquired pneumonia (CAP) and cardiovascular disease
Source: International Congress 2019 – M-health/e-health I
Year: 2019
The effectiveness of TB treatment in patients with gastrointestinal tract disorders, depending on the way of administration of anti-TB drugs
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Impact of genotype on the course of pulmonary tuberculosis in new cases patients of Armenian population
Source: Eur Respir J 2005; 26: Suppl. 49, 453s
Year: 2005
Successful management of a patient with triple infection (MDR-TB/HIV/HCV) using new WHO recommendations
Source: Virtual Congress 2020 – Respiratory infections
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept